ARTA
BMY icon

A.R.T. Advisors’s Bristol-Myers Squibb BMY Stock Holding History

A.R.T. Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$446K Buy
+7,530
New +$496K 24.85% 1
2020
Q4 		– Sell
-17,230
Closed -$1.04M – 78
2020
Q3 		$1.04M Buy
+17,230
New +$1.04M 5.87% 2
2019
Q4 		– Sell
-195,170
Closed -$9.9M – 1346
2019
Q3 		$9.9M Buy
195,170
+181,300
+1,307% +$8.52M 0.5% 22
2019
Q2 		$629K Sell
13,870
-162,100
-92% -$7.55M 0.04% 654
2019
Q1 		$8.4M Buy
175,970
+150,800
+599% +$7.51M 0.5% 16
2018
Q4 		$1.31M Sell
25,170
-182,120
-88% -$9.79M 0.08% 357
2018
Q3 		$12.9M Buy
+207,290
New +$12.3M 0.59% 17
2018
Q2 		– Sell
-99,590
Closed -$6.3M – 1432
2018
Q1 		$6.3M Buy
99,590
+70,100
+238% +$4.51M 0.25% 68
2017
Q4 		$1.81M Sell
29,490
-160,400
-84% -$10M 0.08% 403
2017
Q3 		$12.1M Buy
189,890
+149,100
+366% +$8.71M 0.62% 13
2017
Q2 		$2.27M Buy
+40,790
New +$2.22M 0.12% 235
2016
Q4 		– Sell
-49,200
Closed -$2.65M – 1284
2016
Q3 		$2.65M Sell
49,200
-21,132
-30% -$1.36M 0.86% 8
2016
Q2 		$5.17M Buy
+70,332
New +$4.97M 0.26% 76
2015
Q4 		– Sell
-127,377
Closed -$7.54M – 1469
2015
Q3 		$7.54M Sell
127,377
-233,984
-65% -$14.8M 0.28% 77
2015
Q2 		$24M Sell
361,361
-103,340
-22% -$6.81M 0.8% 3
2015
Q1 		$30M Buy
464,701
+252,333
+119% +$15.8M 1.03% 2
2014
Q4 		$12.5M Buy
+212,368
New +$12M 0.47% 25
2014
Q3 		– Sell
-106,107
Closed -$5.15M – 1316
2014
Q2 		$5.15M Sell
106,107
-159,115
-60% -$7.84M 0.27% 78
2014
Q1 		$13.8M Buy
265,222
+253,359
+2,136% +$13.5M 0.73% 5
2013
Q4 		$630K Sell
11,863
-69,641
-85% -$3.55M 0.03% 678
2013
Q3 		$3.77M Buy
81,504
+33,961
+71% +$1.49M 0.21% 119
2013
Q2 		$2.12M Buy
+47,543
New +$2.06M 0.07% 388

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

A.R.T. Advisors's BMY Position: Q3 2021 in Review

A.R.T. Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q3 2021: 7,530 shares worth $446K. The stake represents 24.85% of the portfolio and ranks #1 among its holdings. This is a return to the name: A.R.T. Advisors previously reported a position in BMY as recently as Q3 2020.

A.R.T. Advisors first reported a position in BMY in Q2 2013 and has held it in 22 quarters since. The position peaked at $30M in Q1 2015. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • A.R.T. Advisors held 7,530 shares of Bristol-Myers Squibb worth $446K as of Q3 2021.
  • Bristol-Myers Squibb was a new A.R.T. Advisors position in Q3 2021.
  • Bristol-Myers Squibb made up 24.85% of A.R.T. Advisors's portfolio in Q3 2021, its #1 holding.
  • A.R.T. Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 22 quarters since.
  • A.R.T. Advisors's Bristol-Myers Squibb position peaked at $30M in Q1 2015.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on A.R.T. Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.